The Effect of Yoga and Laughter Yoga on Increasing the Psychological Resilience of Mothers

NCT ID: NCT05005546

Last Updated: 2022-07-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-08

Study Completion Date

2021-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: The study will carried out in a randomized controlled trial to determine the effect of yoga and laughter yoga on increasing the psychological resilience of mothers with their babies in the Neonatal Intensive Care Unit

Method: The research will be carried out with mothers whose babies are treated in the neonatal intensive care unit. Mothers will be divided into three groups as yoga (n=20), laughter yoga (n=20) and control (n=20) by block randomization method. Research findings; Data Form will obtained by using "Introductory Characteristics Form", "Depression, Anxiety, Stress Scale (DASS-21)" and "Psychological Resilience Scale".

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Starting from the 1st week (5-7 days) after the birth, mothers will be given 10 sessions of laughter yoga (laughter group) and yoga (yoga group) twice a week for 45 minutes.DASS-21 and Resilience Scale will be administered to mothers in all groups at 1st, 3rd and 5th weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Stress Anxiety Psychological Resilience

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental: Yoga

Group Type EXPERIMENTAL

Yoga

Intervention Type BEHAVIORAL

Yoga will be applied to mothers in the yoga group

Experimental: Laughter Yoga

Group Type EXPERIMENTAL

Laughter Yoga

Intervention Type BEHAVIORAL

Laughter Yoga will be applied to mothers in the yoga group

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Yoga

Yoga will be applied to mothers in the yoga group

Intervention Type BEHAVIORAL

Laughter Yoga

Laughter Yoga will be applied to mothers in the yoga group

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mothers who are older than 18 years of age,
* whose gestational week is less than 32 weeks,
* whose baby has been treated in the neonatal intensive care unit for at least one week,
* who have internet access

Exclusion Criteria

* Mothers with a genetic disease or congenital anomaly in their baby
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Adiyaman University Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tuba Koc Ozkan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hasan Kalyoncu University

Gaziantep, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021/085

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.